Nostalgia (12)

The Nostalgia category is split up in two components and basically are the remainders of about 12 years of web-publishing on Cytori Therapeutics, which Company- as you probably know- does not exist any longer and re-named itself to Plus Therapeutics. I just did not completely "destroy" a lot of work done in the past, which at least still has some sentimental value, if not even were assessments that were correct and were voided by other resons. 

First- the "classics" that appeared on the web in the past, describing the potential and future of the Company, which potential never emerged or materialized

Second-some of the articles that I wrote in the past, which still have some "museum- value" in my eyes.

Children categories

Media "Classics"

Media "Classics" (6)

The best write-ups on Cytori from the past.

View items...
Fas´ Favourites from the CYTX-Past

Fas´ Favourites from the CYTX-Past (5)

I selected some articles which I wrote in the past- mainly from the 2011-2013 time period- which I still think are worth reading and which still raises the question mark- what went wrong?

IP issues with human body material and possibly the device? i.e. Celution. many speculations can be made- I still have an urge to find out the truth, but it is diminishing every day, since simply life goes on.

If you are bored and have nothing better to do- have a go at the following articles -

View items...
Monday, 22 February 2016 20:53

Nostalgia articles concerning Cytori

Written by
After some consideration, I decided not to throw all past Cytori content into the waste bin. There were in the past several good articles written, by professional writers i.e. the external media and myself also (I still believe) - so I kept the external stuff as they were under the category heading "Media Classics" and selected a handfull of my own articles, which I liked myself, stuck them in the category "Fas Favourites" and below you see a  two summaries of which articles are contained in those two categories- Thats all- if you do not have better things to do- be my guest and have some nostalgic feelings of "what could have been"
Sunday, 21 February 2016 23:52

Good news from Naples Italy

Written by
A subscriber to the Site had an interesting find of an article published in the Journal of Surgical Research, describing the placebo controlled clinical study of PAD (Peripheral Arterial Disease) patients with chronic ulcers treated with ADRCs from Celution. By my assessment this study is one of several European Celution device based clinical studies, which culminated in Cytori receiving market authorization (added claim to Celution for intended use of: therapy against chronic wounds- reported August 2012). As described in my other article: Another backdoor Slider,  EU regulations allow the device pathway for same day surgical and AUTOLOGOUS procedures, whereby the extracted cells remain property of the patient and ONLY can be used for this SAME patient as per the "Placed on the Market" principle.  This article is presented in "key elements" style instead of my usual long stories to keep our focus on the facts-  
Wednesday, 19 February 2014 07:47

The One that got away

Written by
If there is one thing that MDs and scientists who briefly experiment with fat cells agree upon with their colleagues who devote most of their lives studying these cells than it would be - yes- they seem to improve blood flow nicely. But why that is, has never really been all that clear. When Zuk et al plated the approx. 2% of plastic adherent SVF back in 2001/2 they apparently also did not know, which was evidenced approx. 4 years later in 2006, when UCLA  and Pittsburgh scientists battled in court with the ownership of the invention of the stromal part in SVF at stake. Pittsburgh won that battle, since they could produce a laboratory piece of paper with the handwritten note "Mesenchymal cell?" on it and Judge Consuela Marshall decided to become a free-lance scientist by suggesting that the MSCs must have travelled to the fat from the marrow and just changed properties slightly due to their new environment. Escaping "patent profanity"- patent lawyers call that. Neat story, but nowadays we know better thanks to the monumental work of Dr. Arnold Caplan from 2011- The Mesenchymal Stem Cell- an Injury Drugstore- which you can download at the bottom of this article.
Page 1 of 4

Copyright Information

Copyright Fas Kuiters © 2019-2020 All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.